Tag Archives: Nephros Inc.

Nephros Announces Strategic License and Supply Agreement with Medica S.p.A for Ultrafiltration Products

RIVER EDGE, N.J., April 23, 2012 /PRNewswire via COMTEX/ — Nephros, Inc. /quotes/zigman/4348490 NEPH +7.37% , a medical device company developing and marketing filtration products for therapeutic applications, infection control, and advanced water purification solutions, today announced that the company has entered into a strategic license and supply agreement with Medica S.p.A. Read more of […]

Continue Reading

Nephros Receives initial FDA response to 510(k) Application for Hemodiafiltration System

RIVER EDGE, N.J., November 10, 2011 /PRNewswire-FirstCall/ — Nephros, Inc. (OTC Bulletin Board: NEPH) announced that it has received the initial review by the Food and Drug Administration (“FDA”) of the 510(k) application for marketing clearance of the company’s hemodiafiltration system. Read more of this entry

Continue Reading